Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...

Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose ...

Martin de Bock receives funding from Novo Nordisk, Medtronic, Ypsomed ... Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately ...

The Medtronic MiniMed™ 780G system consists of the following ... is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Click here to read my DXCM ...

By analyzing data from Medtronic diabetes monitoring devices (insulin pumps and glucose monitors), IBM's artificial intelligence computer Watson can predict a low blood sugar problem up to three ...

Medtronic Plc is a medical technology company ... The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded ...

Medtronic sent a safety alert to customers ... diabetes patients based on recordings from an attached continuous glucose monitor (CGM). Around 785,000 systems are implicated in October Class ...

Medtronic's 780g insulin pump automates much ... blood glucose is a major advancement over the point-in-time blood glucose meters that typically provided two to four blood glucose readings in ...

Medtronic PLC investors have been content ... tools for diabetes management including insulin pumps and continuous glucose monitors, neuromodulation devices for chronic pain and movement disorders ...